Umeclidinium Bromide API: Inhalation-Grade Micronized & Injectable LAMAs

Umeclidinium Bromide API: Inhalation-Grade Micronized & Injectable LAMAs

Umeclidinium Bromide API: Inhalation-Grade Micronized & Injectable LAMAs

Umeclidinium Bromide is a long-acting muscarinic acetylcholine antagonist developed by GlaxoSmithKline and approved by the US FDA at the end of 2013 for use in combination with vilanterol, a b2 agonist, for the treatment of chronic obstructive pulmonary disease. Due to umeclidinium’s poor oral bioavailability, the drug is administrated by inhalation as dry powder.

Umeclidinium Bromide Identification Data

Product Umeclidinium Bromide
CAS Number 869113-09-7
MF C29H34BrNO2
MW 508.48976

Global Supply Chain Resilience for Respiratory APIs

Developing LAMA and combination respiratory therapies requires extremely stringent chemical controls and dependable long-term supply agreements. Micro Orgo Chem ensures batch-to-batch aerodynamic consistency and absolute lead-time security through highly automated crystallization lines at our Vapi works. We provide exhaustive solid-state stability studies and Open/Closed DMF support, helping global generic formulators launch high-compliance inhalation platforms with complete regulatory safety.

Anti-Asthmatic/COPD Product Portfolio

Our Product Category

Our Clients

For bulk procurement or technical specifications, contact our sales team.

+91 8451062225

+91 9082984052